Company
Ionctura
Our mission is to develop high impact, low disruption therapies that extend healthspan.
Also known as iOnctura SA
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Genève, Switzerland
- Founded
- 2017
- Employees
- more than 20 team membersSource (opens in a new tab)
- Legal name
- iOnctura SA
- ionctura.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the tumor-stroma-immune interface.
Products
- Other
- Cambritaxestat (IOA-289)
- Web
- Cambritaxestat (IOA-289)
- Other
- IOA-359
- Web
- IOA-359
- Other
- Roginolisib (IOA-244)
- Web
- Roginolisib (IOA-244)
Loading relationship preview